[MagVenture] FDA clears MagVenture TMS Therapy for OCD

The FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD) in adult patients*. This marks the second FDA cleared indication for MagVenture TMS Therapy to accompany our clearance for Major Depressive Disorder**.

Click here to read the full article (opens in a new window).